Xiaodong Ling

机构：Harbin Medical University, Third Affiliated Hospital of Harbin Medical University · ORCID：0000-0001-8728-893X

发表论文 54 篇 · 总被引 639 次 · h-index 15

代表论文

Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma (2023 · EBioMedicine · 被引 59)
Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study (cohort study) (2023 · International Journal of Surgery · 被引 45)
METTL3-mediated deficiency of lncRNA HAR1A drives non-small cell lung cancer growth and metastasis by promoting ANXA2 stabilization (2024 · Cell Death Discovery · 被引 15)
A comprehensive prognostic and immunological implications of PFKP in pan-cancer (2024 · Cancer Cell International · 被引 9)
Intratumoral and peritumoral heterogeneity based on CT to predict the pathological response after neoadjuvant chemoimmunotherapy in esophageal squamous cell carcinoma (2025 · International Journal of Surgery · 被引 7)
Experimental and numerical study on explosion resistance of polyurea-coated shelter in petrochemical industry (2024 · Scientific Reports · 被引 5)